[1]
Correa-González, N.F., Díaz-Cortés, D. and Muñoz Velandia, O.M. 2024. Intravenous immunoglobulin costs are higher for off-label indications in a high-complexity hospital in Colombia. Universitas Medica. 64, 4 (Jan. 2024). DOI:https://doi.org/10.11144/Javeriana.umed64-4.offl.